Details for New Drug Application (NDA): 022013
✉ Email this page to a colleague
The generic ingredient in OLUX E is clobetasol propionate. There are fourteen drug master file entries for this compound. Forty suppliers are listed for this compound. Additional details are available on the clobetasol propionate profile page.
Summary for 022013
Tradename: | OLUX E |
Applicant: | Norvium Bioscience |
Ingredient: | clobetasol propionate |
Patents: | 2 |
Medical Subject Heading (MeSH) Categories for 022013
Profile for product number 001
Active Rx/OTC/Discontinued: | DISCN | Dosage: | AEROSOL, FOAM;TOPICAL | Strength | 0.05% **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | ||||
Approval Date: | Jan 12, 2007 | TE: | RLD: | Yes | |||||
Patent: | ⤷ Sign Up | Patent Expiration: | Nov 5, 2028 | Product Flag? | Y | Substance Flag? | Delist Request? | ||
Patented Use: | TREATMENT OF CORTICOSTEROID-RESPONSIVE DERMATOSES | ||||||||
Patent: | ⤷ Sign Up | Patent Expiration: | Aug 31, 2025 | Product Flag? | Y | Substance Flag? | Delist Request? | ||
Patented Use: | TREATMENT OF CORTICOSTEROID-RESPONSIVE DERMATOSES |
Expired US Patents for NDA 022013
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
---|---|---|---|---|---|---|---|
Norvium Bioscience | OLUX E | clobetasol propionate | AEROSOL, FOAM;TOPICAL | 022013-001 | Jan 12, 2007 | ⤷ Sign Up | ⤷ Sign Up |
Norvium Bioscience | OLUX E | clobetasol propionate | AEROSOL, FOAM;TOPICAL | 022013-001 | Jan 12, 2007 | ⤷ Sign Up | ⤷ Sign Up |
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |
Complete Access Available with Subscription